AIM ImmunoTech Inc Stock Price. Everything You Need To Know About The AIM ImmunoTech Inc Stock!
AIM ImmunoTech, Inc. is an immuno-pharma company headquartered in Ocala, Florida. The company, which currently employs 22 full-time employees, focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses, and immune-deficiency disorders.
AIM ImmunoTech’s flagship products are Ampligen (rintatolimod) and Alferon N Injection (Interferon Alfa-N3). Ampligen is a drug of large macromolecular ribonucleic acid (RNA) molecules approved for commercial sale in the Argentine Republic for the treatment of severe chronic fatigue syndrome (CFS). In the United States, it’s undergoing clinical development for the treatment of certain cancers and ME/CFS.
Alferon N Injection is a natural-source, multi-species alpha interferon approved for sale in the United States and Argentina for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older.
As an immuno-pharma company, AIM ImmunoTech is dedicated to finding innovative solutions to complex health issues. Investors interested in the biopharmaceutical industry may want to keep an eye on AIM ImmunoTech’s progress and stocks share price today, premarket activity, and market cap. However, it’s important to conduct thorough research and analysis before making any investment decisions. The biopharmaceutical industry can be highly competitive and subject to regulatory approvals and changes in healthcare policies. Therefore, it’s vital to stay up to date with industry insights and trends.
AIM ImmunoTech Inc Stock Price. Everything You Need To Know About The AIM ImmunoTech Inc Stock! performance
- Employees 22
- Company HQ Ocala
- Website https://aimimmuno.com/
- AIM Asset Type Common Stock
- AIM Market Capitalization 21.7M
- Earnings Per Share -0.64
- Dividends Per Share None
- Dividend Date 2019-06-11
- Quarterly Earnings Growth 0
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in exciting opportunities? Look no further than AIM ImmunoTech, a stock that offers tremendous potential for growth. With Zorion, an investment platform dedicated to bringing real US stocks and Pre-IPO companies to retail investors, you can now access insights and recommendations to make informed investment decisions. AIM ImmunoTech is a leading biotech company specializing in innovative immunotherapy treatments. By investing in AIM ImmunoTech, you can support their groundbreaking research and development efforts aimed at combating various diseases, including cancer and viral infections. To invest in AIM ImmunoTech from Malaysia, Thailand, Indonesia, or Vietnam, simply sign up with Zorion to gain access to this exciting opportunity. Take advantage of the resources and educational materials provided to enhance your investment knowledge and make sound investment choices. Start investing with Zorion today and unlock your potential for remarkable returns!” Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to expand your investment portfolio? Look no further than AIM ImmunoTech stock. As an expert in content marketing at Zorion, I can guide you on how to purchase this promising stock hassle-free. AIM ImmunoTech offers an investment opportunity in cutting-edge biotechnology, focusing on immune-based therapies to combat diseases like cancer and viral infections. With our investment insights and recommendations, you can make informed decisions about adding AIM ImmunoTech to your portfolio. Our platform also provides easy access to resources and educational materials, empowering you to enhance your investment knowledge. Start investing in AIM ImmunoTech today and unlock the potential of biotech innovation.”
